Perucca, E, Beghi, E, Dulac, O, Shorvon, S, Tomson, T. Assessing risk to benefit ratio in antiepileptic drug therapy. Epilepsy Res 2000; 41:107–39.Google Scholar

Berg, A T, Shinnar, S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 1991; 41:965–72.Google Scholar

Hauser, W A, Rich, S S, Lee, J R, Annegers, J F, Anderson, V E. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 1998; 338:429–34.CrossRefGoogle ScholarPubMed

First Seizure Trial Group (FIRST Group). Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic clonic seizure. Neurology 1993; 43:478–83.Google Scholar

Marson, A, Jacoby, A, Johnson, A, et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 2005; 365:2007–13.CrossRefGoogle ScholarPubMed

Kim, L G, Johnston, T L, Marson, A G, Chadwick, D W; MRC MESS Study group. Prediction of risk of recurrence after a single seizure and early epilepsy: further results from the MESS trial. Lancet Neurol 2006; 5:317–22.Google Scholar

Perucca, E, Dulac, O, Shorvon, S, Tomson, T. Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation. CNS Drugs 2001; 15:609–21.CrossRefGoogle ScholarPubMed

Patsalos, P N, Berry, D J, Bourgeois, B F, et al. Antiepileptic drugs – best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008; 49:1239–76.CrossRefGoogle ScholarPubMed

Specchio, L M, Beghi, E. Should antiepileptic drugs be withdrawn in seizure-free patients? CNS Drugs 2004; 18:201–12.CrossRefGoogle ScholarPubMed

Chadwick, D, Taylor, J, Johnson, T. Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. The MRC Antiepileptic Drug Withdrawal Group. Epilepsia 1996; 37:1043–50.CrossRefGoogle ScholarPubMed

Schmidt, D, Löscher, W. Uncontrolled epilepsy following discontinuation of antiepileptic drugs in seizure-free patients: a review of current clinical experience. Acta Neurol Scand 2005; 111:291–300.CrossRefGoogle ScholarPubMed

Glauser, T, Ben-Menachem, E, Bourgeois, B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006; 47:1094–120.Google Scholar

Perucca, E, Tomson, T. The pharmacological treatment of epilepsy in adults. Lancet Neurol 2011; 10:446–56.CrossRefGoogle ScholarPubMed

French, J A, Kanner, A M, Bautista, J, et al. Efficacy and tolerability of the new antiepileptic drugs, I: treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2004; 45:401–09.Google ScholarPubMed

National Institute for Clinical Excellence. Clinical Guideline 20. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. October 2004. Available at: www.nice.org.uk/nicemedia/live/10954/29532/29532.pdf (accessed January 1, 2011).Google Scholar

Scottish Intercollegiate Guidelines Network. Diagnosis and management of epilepsy in adults. A national clinical guideline. April 2003, updated October 20, 2005. Available at: www.sign.ac.uk/pdf/sign70.pdf (accessed January 1, 2011).Google Scholar

Brodie, M J, Perucca, E, Ryvlin, P, et al. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007; 68:402–08.CrossRefGoogle ScholarPubMed

Glauser, T A, Cnaan, A, Shinnar, S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010; 362(9):790–99.Google Scholar

Marson, A G, Al-Kharusi, A M, Alwaidh, M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369:1000–15.Google ScholarPubMed

Marson, A G, Al-Kharusi, A M, Alwaidh, M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369:1016–26.Google ScholarPubMed

Kale, R, Perucca, E. Revisiting phenobarbital for epilepsy. Br Med J 2004; 329:1199–200.CrossRefGoogle ScholarPubMed

Harden, C L, Meador, K J, Pennell, P B, et al. Practice Parameter update: Management issues for women with epilepsy – focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes. Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and American Epilepsy Society. Epilepsia 2009; 50:1237–46.Google Scholar

Meador, K J, Baker, G A, Browning, N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009; 360:1597–605.CrossRefGoogle ScholarPubMed

Tomson, T, Battino, D, Bonizzoni, E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011; 10(7):609–17.CrossRefGoogle ScholarPubMed

Bialer, M, Midha, K K. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability. Epilepsia 2010; 51:941–50.Google Scholar

Heaney, D C, Sander, J W. Antiepileptic drugs: generic versus branded treatments. Lancet Neurol 2007; 6(5):465–68.CrossRefGoogle ScholarPubMed

Perucca, E, Albani, F, Capovilla, G, et al. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs. Epilepsia 2006; 47(Suppl 5):16–20.Google Scholar

Banahan, B F, Bonnarens, J K, Bentley, J P. Generic substitution of NTI drugs: issues for formulary committee consideration. Formulary 1998; 33:1082–96.Google Scholar

Leppik, I. Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population. Epilepsy Res Suppl 1988; 1:85–90.Google Scholar

Krauss, G L, Caffo, B, Chang, Y-T, Hendrix, C W, Chuang, K. Assessing bioequivalence of generic antiepileptic drugs. Ann Neurol 2011; 70:221–28.Google Scholar

Andermann, F, Duh, M, Gosselin, A, Paradis, P. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes. Epilepsia 2007; 48(3):464–69.Google Scholar

Erickson, S C, Le, L, Ramsey, S D, et al. Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy. Epilepsia 2011; 52:1365–71.CrossRefGoogle ScholarPubMed

Kesselheim, A S, Stedman, M R, Bubrick, E J, et al. Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs 2010; 70:605–21.CrossRefGoogle ScholarPubMed

Liow, K, Barkley, G, Pollard, J, et al. Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy. Neurology 2007; 68(16):1249–50.CrossRefGoogle ScholarPubMed

Shorvon, S. Handbook of Epilepsy Treatment, 3rd edition. Chichester: Wiley-Blackwell, 2010.CrossRefGoogle Scholar

Caraballo, R, Fejerman, N. Tratamiento de las epilepsias. Buenos Aires: Editorial Panamericana, 2009.Google Scholar

Levy, R H, Mattson, R H, Meldrum, B S, et al. Antiepileptic Drugs, 5th edition. Philadelphia: Lippincott Williams & Wilkins, 2002.Google Scholar

Bromfield, E B, Cavazos, J E, Sirven, J I, editors. An Introduction to Epilepsy [Internet]. Chapter 3. West Hartford, CT: American Epilepsy Society, 2006.Google Scholar

Patsalos, N, Perucca, E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2003; 2:347–56.Google Scholar

Patsalos, N, Perucca, E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2003; 2:473–81.Google Scholar

Panayiotopoulos, C. Atlas of Epilepsies. London: Springer, 2011.Google Scholar

Engel, J, Pedley, T. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott Williams & Wilkins, 2007.Google Scholar

Engel, J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001; 42:796–803.CrossRefGoogle ScholarPubMed

Berg, A T, Berkovic, S F, Brodie, M J, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 2010; 51:676–85.Google Scholar

Fejerman, N, Caraballo, R. Benign Focal Epilepsies in Infancy, Childhood and Adolescence. Paris: John Libbey Eurotext, 2007.Google Scholar

Meyer, A C, Dua, T, Ma, J, Saxena, S, Birbeck, G. Global disparities in the epilepsy treatment gap: a systematic review. Bulletin of the World Health Organization. 2010;88(4):260–66.Google Scholar

WHO, Global Campaign Against Epilepsy, International Bureau for Epilepsy, International League Against Epilepsy. Atlas: Epilepsy Care in the World 2005. Program for Neurological Diseases and Neuroscience, Department of Mental Health and Substance Abuse, Geneva: World Health Organization; 2005.Google Scholar

Nizamie, S H, Akthar, S, Banerjee, I, Goyal, N. Health care delivery model in epilepsy to reduce treatment gap: World Health Organization study from a rural tribal population of India. Epilepsy Research. 2009;84(2–3):146–52.CrossRefGoogle ScholarPubMed

Mbuba, C K, Ngugi, A K, Newton, C R, Carter, J A. The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia. 2008;49(9):1491–503.CrossRefGoogle ScholarPubMed

Cameron, A, Bansal, A, Dua, T, et al. Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries. Epilepsia. 2012;53(6):962–69.Google Scholar

Chomba, E N, Haworth, A, Mbewe, E, et al. The current availability of antiepileptic drugs in Zambia: implications for the ILAE/WHO “out of the shadows” campaign. American Journal of Tropical Medicine and Hygiene. 2010;83(3):571–74.CrossRefGoogle ScholarPubMed

Mac, T L, Le, V T, Vu, A N, Preux, P M, Ratsimbazafy, V. AEDs availability and professional practices in delivery outlets in a city center in southern Vietnam. Epilepsia. 2006;47(2):330–34.Google Scholar

Laroche, M L, Traore, H, Merle, L, et al. Quality of phenobarbital solid-dosage forms in the urban community of Nouakchott (Mauritania). Epilepsia. 2005;46(8):1293–96.CrossRefGoogle ScholarPubMed

Chisholm, D, Who, C. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis. Epilepsia. 2005;46(5):751–59.Google Scholar

Watts, A E. A model for managing epilepsy in a rural community in Africa. British Medical Journal. 1989;298(6676):805–07.Google Scholar

Feksi, A T, Kaamugisha, J, Sander, J W, Gatiti, S, Shorvon, S D. Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group). Lancet. 1991;337(8738):406–09.Google Scholar

Pal, D K, Das, T, Sengupta, S. Comparison of key informant and survey methods for ascertainment of childhood epilepsy in West Bengal, India. International Journal of Epidemiology. 1998;27(4):672–76.CrossRefGoogle ScholarPubMed

Gourie-Devi, M, Satishchandra, P, Gururaj, G. Epilepsy control programme in India: a district model. Epilepsia. 2003;44(Suppl 1):58–62.CrossRefGoogle ScholarPubMed

Mani, K S, Rangan, G, Srinivas, H V, Srindharan, V S, Subbakrishna, D K. Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur study. Lancet. 2001;357(9265):1316–20.Google Scholar

Wang, W Z, Wu, J Z, Wang, D S, et al. The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology. 2003;60(9):1544–45.CrossRefGoogle Scholar

Wang, W Z, Wu, J Z, Ma, G Y, et al. Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China. Lancet Neurology. 2006;5(1):46–52.Google Scholar

Kwan, P, Wang, W, Wu, J, et al. Long-term outcome of phenobarbital treatment for epilepsy in rural China: a prospective cohort study. Epilepsia. 2013;54(3):537–42.CrossRefGoogle ScholarPubMed

Ding, D, Zhang, Q, Zhou, D, et al. Cognitive and mood effects of phenobarbital treatment in people with epilepsy in rural China: a prospective study. Journal of Neurology, Neurosurgery, and Psychiatry. 2012;83(12):1139–44.Google Scholar

Indian Epilepsy Society & Indian Epilepsy Association. Guidelines for the Management of Epilepsy in India. Guragaon: Indian Epilepsy Society & Indian Epilepsy Association; 2008, 50.Google Scholar

World Health Organization. mhGAP Intervention Guide for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings, 2010. Available from: http://whqlibdoc.who.int/publications/2010/9789241548069_eng.pdf?ua=1.Google Scholar

Tran, D S, Odermatt, P, Strobel, M, Preux, P M. Une crise d’epilespie fatale au Laos. Med Trop 2005;65(6):607.Google Scholar

Barennes, H, Tran, D S, Latthaphasavang, V, Preux, P M, Odermatt, P. Epilepsy in Lao PDR: From research to treatment intervention. Neurol Asia 2008;13:27–31.Google Scholar

Barennes, H, Sengkhamyong, K, Sambany, E M, et al. Children’s access to treatment for epilepsy: experience from the Lao People’s Democratic Republic. Arch Dis Child 2011;96(3):309–13.CrossRefGoogle ScholarPubMed

Barennes, H, Harimanana, A, Vorachit, S, Chivorakoun, P. The Lao initiative on access to treatment for epilepsy. Neurol Asia 2011;16:59–61.Google Scholar

Chivorakoun, P, Harimanana, A, Clavel, S, Jousseaume, S, Barennes, H. [Epilepsy in Lao Popular Democratic Republic: difficult procurement of a first-line antiepileptic contributes to widening the treatment gap]. Rev Neurol (Paris) 2012;168(3):221–29.Google ScholarPubMed

Erhua, L, Herindrainy, P, Chanthavilay, P, Barennes, H. A qualitative survey to understand epilepsy a neglected disease with 90% treatment gap in Laos. Bull Soc Path Exot 2008;S:30–31.Google Scholar

Tran, D S, Odermatt, P, Le, T O, et al. Prevalence of epilepsy in a rural district of central Lao PDR. Neuroepidemiology 2006;26(4):199–206.CrossRefGoogle Scholar

Tran, D S, Odermatt, P, Delneuville, L, et al. Anxiété et dépression chez des patients atteints d’épilepsie à la République Démocratique Populaire du Laos. Epilepsies 2007;20:1–5.Google Scholar

Tran, D S, Odermatt, P, Singphuoangphet, S, et al. Epilepsy in Laos: knowledge, attitudes, and practices in the community. Epilepsy Behav 2007;10(4):565–70.CrossRefGoogle ScholarPubMed

Tran, D S, Odermatt, P, Le, O T, et al. Risk factors for epilepsy in rural Lao PDR: a case-control study. Southeast Asian J Trop Med Public Health 2007;38(3):537–42.Google ScholarPubMed

Tran, D S, Zen, J, Strobel, M, et al. The challenge of epilepsy control in deprived settings: low compliance and high fatality rates during a community-based phenobarbital program in rural Laos. Epilepsia 2008;49(3):539–40.Google Scholar

Harimanana, A, Chivorakul, P, Souvong, V, Preux, P M, Barennes, H. Is insufficient knowledge of epilepsy the reason for low levels of healthcare in the Lao PDR? BMC Health Serv Res 2013;13:41.CrossRefGoogle ScholarPubMed

Harimanana, A, Clavel, S, Chivorakul, P, et al. Associated factors with adherence to antiepileptic drug in the capital city of Lao PDR. Epilepsy Res 2013;104(1–2):158–66.CrossRefGoogle ScholarPubMed

Odermatt, P, Ly, S, Simmala, C, et al. Availability and costs of antiepileptic drugs and quality of phenobarbital in Vientiane municipality, Lao PDR. Neuroepidemiology 2007;28(3):169–74.Google Scholar

Tran, D S, Odermatt, P, Le, T O, et al. Prevalence of epilepsy in a rural district of central Lao PDR. Neuroepidemiology 2006;26(4):199–206.CrossRefGoogle Scholar

Wang, W Z, Wu, J Z, Wang, D S, et al. The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology 2003;60(9):1544–45.CrossRefGoogle Scholar

Jeon, H K, Yong, T S, Sohn, W M, et al. Current status of human taeniasis in Lao People’s Democratic Republic. Korean J Parasitol 2013;51(2):259–63.Google Scholar

Fadiman, A. The Spirit Catches You and You Fall Down. A Hmong Child, Her American Doctors, and the Collision of Two Cultures. New York, NY: Farrar, Straus and Giroux; 1998.Google Scholar

Tran, D S, Odermatt, P, Singphuoangphet, S, et al. Epilepsy in Laos: knowledge, attitudes, and practices in the community. Epilepsy Behav 2007;10(4):565–70.Google Scholar

Barennes, H, Chivorakul, P. Groupe de travail Epilepsie. www.ifmt.auf.org/rubriquephp3?id_rubrique=62, 2011.Google Scholar